Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Tirzepatide improves insulin sensitivity and slows gastric emptying, both of which can drive blood glucose lower than normal between meals
Tirzepatide is a dual GIP and GLP-1 receptor agonist that supports metabolic signaling beyond appetite control alone
Just read this and shared with my group
While its pain-relieving effects are not as long-lasting as traditional painkillers like morphine, it appears to work quickly (within hours) to mitigate both inflammatory and nociceptive (injury-related) pain
10.2337/db16-1009 Summary Keywords GLP-1 receptor agonist, molecular mechanisms, gut microbiota, multi-organ protection, therapeutic repurposing Citation Gong B, Li C, Shi Z, Wang F, Dai R, Chen G and Su H (2025) GLP-1 receptor agonists: exploration of transformation from metabolic regulation to multi-organ therapy
